170 results on '"Maremmani, A. G. I."'
Search Results
2. Anxiety Disorder in Heroin Use Disorder Patients
3. Alcohol Use Disorder and Polytoxicomania in Heroin Use Disorder Patients
4. Chronic Psychosis in Dual Disorder Heroin Use Disorder Patients
5. Guiding Principles for the Treatment of Dual Disorder Patients
6. Mood Disorders in Dual Disorder Heroin Use Disorder Patients
7. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View
8. Heroin addiction history, psychopathology and stress sensitivity in a sample of migrants to Italy
9. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View
10. Is the SCL90-based five-dimensional structure able to differentiate heroin use disorder patients with low and high benzodiazepine dependence symptomatology?
11. Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
12. Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
13. Trends of hospital admissions for alcohol, cannabinoids, benzodiazepines and heroin-related intoxications among children, adolescents and young adults in Slovenia in the years 1999-2019 and the possible impact of economic crisis.
14. The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
15. Insight in dual disorder heroin addicts. Are they able to request adequate treatment?
16. Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
17. SY15-2PAIN KILLERS AND SUBSTITUTION MEDICATIONS USE IN PATIENTS LOOKING FOR AGONIST OPIOID TREATMENT IN NORTHERN AND SOUTHERN ITALY, USING A 18-MONTH SURVEY METHODOLOGY
18. Quality of life differential changes from psychopathological episodes through recovery in Heroin Addiction.
19. The psychopathology specific to Substance Use Disorder is able to discriminate between young people with and without Problematic Internet Use
20. Is the psychopathology specific of Substance Use Disorder able to differentiate problematic and non-problematic recreational drinkers?
21. Trends in cigarette smoking among Italian substance use disorder patients.
22. The Conceptual Framework of Dual Disorders and Its Flaws
23. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
24. Does impulsivity increase the risk of developing a pathological condition?
25. Towards a specific psychopathology of substance use disorder: Comparison between heroin use disorder and chronic psychotic patients
26. Convergent validity of five-dimension psychopathology of addiction: Relationships with the Tridimensional Personality Questionnaire.
27. Convergent validity of five-dimension psychopathology of Addiction: Relationships with aggressive behaviour.
28. Early-readmission after Agonist Opioid Treatment in five European countries. A drug addiction health policy challenge?
29. Personality profiles and aggressive behaviour of heroin use disorder patients compared with non-substance-use peers
30. Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
31. Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
32. Exploring the Depressive Syndrome of Heroin Use Disorder patients. Relationships between Worthlessness/Being Trapped, Deficit Reward and Post-Withdrawal Syndromes.
33. Further evidence of a psychopathology specific to Substance Use Disorder. Relationships between psychopathological dimensions and alcohol craving in recreational drinkers.
34. Contemporary Perspective on Addictive Behaviors: Underpinning Mechanisms, Assessment, and Treatment
35. Psychopathological syndromes and risk of alcoholism in Heroin Use Disorder patients compared with non-substance-use peers.
36. Is the non-medical use of pregabalin related to reward/relief craving coupled with an Unbalanced Opioid System?
37. Toward patient-tailored therapy in agonist opioid treatment: The role of psychopathology, craving behavioural covariates, stress reaction and methadone blood concentration. A case series.
38. Is the psychopathology specific to Substance Use Disorder able to differentiate problematic and non-problematic recreational drinkers?
39. Anti-HCV treatment for opiate addicts: Clinical and immunological issues.
40. Can the psychopathology specific to Substance Use Disorder distinguish between reward and relief craving?
41. Aggressive Behavior and Substance Use Disorder: The Heroin Use Disorder as a Case Study.
42. Prominent psychopathological and clinical characteristics of Heroin Post- Traumatic Stress Disorder Spectrum patients during treatment.
43. A prospective study of psychopathology stability and changes after 3-month residential treatment in Italian Substance Use Disorder patients.
44. Nearly thirty years of experience of real-world long-term treatment with Agonists Opioid.
45. Substance Dependence Among Bipolar, Unipolar Depression and Psychotic Homeless: A Canadian National Study
46. Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis
47. Contemporary Perspective on Addictive Behaviors: Underpinning Mechanisms, Assessment, and Treatment
48. Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
49. Possible trajectories of addictions: The role of bipolar spectrum
50. Toward the Identification of a Specific Psychopathology of Substance Use Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.